CBD MediHaze

CBD MediHaze is a sativa-leaning hybrid prized for its elevated cannabidiol levels and therapeutic applications. This cultivar was developed by crossing two renowned strains—Super Silver Haze and Nevil Haze—with a CBD-dominant genetics contributor. The cannabinoid profile ranges from 6-15% THC paired with a CBD ratio spanning 1:1 to 1:10. The genetic composition reflects 80% sativa and 20% indica heritage. This variety completes its flowering cycle in 9-10 weeks, with late-season harvesting possible through mid-October. Indoor growers can expect yields between 450-550 grams per square meter. Despite its sativa-forward genetics, the plant exhibits moderate vertical growth and demonstrates vigorous flowering activity during the final stages of maturation. The aroma profile combines peppery and cooling menthol notes with pine undertones, complemented by hints of citrus and subtle sweetness.